These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34674567)

  • 1. Latency-associated Peptide Degradation Fragments Produced in Stellate Cells and Phagocytosed by Macrophages in Bile Duct-ligated Mouse Liver.
    Inoue I; Qin XY; Masaki T; Mezaki Y; Matsuura T; Kojima S; Furutani Y
    J Histochem Cytochem; 2021 Nov; 69(11):723-730. PubMed ID: 34674567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of acute liver injury by suppressing plasma kallikrein-dependent activation of latent TGF-β.
    Li M; Qin XY; Furutani Y; Inoue I; Sekihara S; Kagechika H; Kojima S
    Biochem Biophys Res Commun; 2018 Oct; 504(4):857-864. PubMed ID: 30219233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L(59) TGF-β LAP degradation products serve as a promising blood biomarker for liver fibrogenesis in mice.
    Hara M; Inoue I; Yamazaki Y; Kirita A; Matsuura T; Friedman SL; Rifkin DB; Kojima S
    Fibrogenesis Tissue Repair; 2015; 8():17. PubMed ID: 26379781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis.
    Hara M; Kirita A; Kondo W; Matsuura T; Nagatsuma K; Dohmae N; Ogawa S; Imajoh-Ohmi S; Friedman SL; Rifkin DB; Kojima S
    Springerplus; 2014; 3():221. PubMed ID: 24877031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease.
    Yokoyama H; Masaki T; Inoue I; Nakamura M; Mezaki Y; Saeki C; Oikawa T; Saruta M; Takahashi H; Ikegami M; Hano H; Ikejima K; Kojima S; Matsuura T
    Heliyon; 2019 Feb; 5(2):e01231. PubMed ID: 30815603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
    Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
    Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
    Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells.
    Roth-Eichhorn S; Kühl K; Gressner AM
    Hepatology; 1998 Dec; 28(6):1588-96. PubMed ID: 9828223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats.
    Zhao XM; Zhang J; Liang YN; Niu YC
    Dig Dis Sci; 2020 Oct; 65(10):2925-2936. PubMed ID: 31900718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathway.
    Song X; Shi J; Liu J; Liu Y; Yu Y; Qiu Y; Cao Z; Pan Y; Yuan X; Chu Y; Wu D
    Mol Med; 2022 Jul; 28(1):80. PubMed ID: 35842576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis.
    Li Y; Lua I; French SW; Asahina K
    Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G262-72. PubMed ID: 26702136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
    Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
    Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-Associated Virus Serotype 2 Vector-Mediated Reintroduction of microRNA-19b Attenuates Hepatic Fibrosis.
    Brandon-Warner E; Benbow JH; Swet JH; Feilen NA; Culberson CR; McKillop IH; deLemos AS; Russo MW; Schrum LW
    Hum Gene Ther; 2018 Jun; 29(6):674-686. PubMed ID: 29281894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
    Tan Z; Liu Q; Jiang R; Lv L; Shoto SS; Maillet I; Quesniaux V; Tang J; Zhang W; Sun B; Ryffel B
    Cell Mol Immunol; 2018 Apr; 15(4):388-398. PubMed ID: 28194023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
    Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
    Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway.
    Huang TJ; Ren JJ; Zhang QQ; Kong YY; Zhang HY; Guo XH; Fan HQ; Liu LX
    Biomed Pharmacother; 2019 Aug; 116():109034. PubMed ID: 31152924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.
    Olsen AL; Sackey BK; Marcinkiewicz C; Boettiger D; Wells RG
    Gastroenterology; 2012 Apr; 142(4):928-937.e3. PubMed ID: 22202457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Expression of S100B and RAGE in a Mouse Model of Bile Duct Ligation-induced Liver Fibrosis.
    Park JW; Kim MJ; Kim SE; Kim HJ; Jeon YC; Shin HY; Park SJ; Jang MK; Kim DJ; Park CK; Choi EK
    J Korean Med Sci; 2021 Apr; 36(14):e90. PubMed ID: 33847081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.